NovaBay Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
NovaBay Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2012 to 2023.
  • NovaBay Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $22K, a 64.5% decline year-over-year.
  • NovaBay Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $227K, a 22% decline year-over-year.
  • NovaBay Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $291K, a 32.3% increase from 2022.
  • NovaBay Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $220K, a 76.4% decline from 2021.
  • NovaBay Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $933K, a 75.4% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $291K +$71K +32.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 $220K -$713K -76.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 $933K +$401K +75.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $532K +$46K +9.47% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2019 $486K -$185K -27.6% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-29
2018 $671K -$1.87M -73.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-25
2017 $2.54M +$791K +45.2% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-26
2016 $1.75M +$369K +26.7% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-29
2015 $1.38M +$340K +32.6% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-21
2014 $1.04M +$24K +2.36% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-23
2013 $1.02M -$522K -33.9% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-04
2012 $1.54M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.